Renin-angiotensin-aldosterone system inhibitors - Summary of recommendations and evidence | ||
---|---|---|
Administer angiotensin-converting enzyme (ACE) inhibitors to intermediate- and high-risk patients with LV dysfunction, high blood pressure, or DM. | I | A |
Administer angiotensin II receptor blockers to intermediate- and high-risk patients with contraindications to ACE inhibitors. | I | C |
Use spironolactone in patients with NSTE-ACS, LVEF ≤ 35%, HF symptoms, or a history of DM. | I | C |
Administer ACE inhibitors to all intermediate- and high-risk patients. | IIb | B |